MedPath

1540nm Non Ablative Fractional Laser Treatment of Scars

Phase 4
Completed
Conditions
Scars
Interventions
Procedure: laser treatment
Procedure: treatment without laser
Registration Number
NCT01056211
Lead Sponsor
University Hospital, Ghent
Brief Summary

Scars are a frequent reason of consultation in a dermatological clinic. Their cosmetic aspect can play a key role in patient satisfaction and self-image.

Non ablative fractional infra-red laser treatment is a new concept in the laser field using arrays of microscopic thermal damage patterns to stimulate a wound healing response. There are different reports on the positive effect of these type of laser treatment in the treatment of acne scarring, striae, rythides, hypopigmented and hypertrophic scars.

The low morbidity of the treatment and the lack of satisfying treatment regimes for different types of scars makes it attractive to investigate the efficacy and safety of 4 treatment with the 1540nm non ablative fractional laser in the treatment of scars.

Objectives:

* To evaluate the efficacy of 4 laser treatments with Starlux 300 Lux 1540nm Fractional laser handpiece ( Palomar Medical Technologies ) 1 and 3 month after the last laser treatment for 3 different "scar" patient groups :

1. Patients with hypopigmented scars

2. Patients with hypertrophic scars

3. Patients with scars due to grafts and reconstructions in the head and neck region.

* To evaluate the treatment related pain. on a categorical scale from 0-10

* To evaluate the adverse effect of 1540nm fractional laser versus untreated control in the 3 patient groups.

The study design is a prospective single blinded randomised within-patient controlled study The study involves 6 visits.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
90
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
hypertrophic scars treated with laserlaser treatment-
hypopigmented scars treated with laserlaser treatmentpatients with hypopigmented scars treated with Starlux 300 Lux 1540nm Fractional laser hand piece
scars due to grafts and reconstructions treated with laserlaser treatmentscars due to grafts and reconstructions in the head and neck region
grafts and reconstructions scars not treated with lasertreatment without laserscars due to grafts and reconstructions in the head and neck region
hypopigmented scars treated without lasertreatment without laserpatients with hypopigmented scars treated without laser
hypertrophic scars not treated with lasertreatment without laser-
Primary Outcome Measures
NameTimeMethod
Evaluation of the adverse effect of 1540nm fractional laser versus untreated control siteat 1 and 3 months
efficacy of 4 laser treatments with Starlux 300 Lux 1540nm Fractional handpiece (Palomar Medical Technologies) 1 and 3 months after the last laser treatment in 3 different "scar" patient groupsat 1 and 3 months
Evaluation of the treatment related painat 1 and 3 months
Secondary Outcome Measures
NameTimeMethod
Compare different clinical scar assessment tools that can be used in the evaluation of clinical efficacy of the laser treatmentat 1 and 3 months after treatment
Physician assessment for the treated and control region (PhGA)at 1 and 3 months after treatment
patient assessment for the treated and control regionat 1 and 3 months after treatment
Evaluation of skin redness and pigmentationat 1 and 3 months after treatment
Evaluation of histological difference in treated an non treated parts of the scarat 3 months after treatment
Photografic documentation of scar improvementat 1 and 3 months after treatment

Trial Locations

Locations (1)

Univerisity Hospital Ghent

🇧🇪

Ghent, Belgium

© Copyright 2025. All Rights Reserved by MedPath